by
.png)
International Desk, May 24, 2025: Dr. Muhammad Yunus, the Chief Adviser of Bangladesh’s interim government, has threatened to resign due to a lack of political and military support in preparing the country for elections, sparking widespread discussion both nationally and internationally. The New York Times published a report highlighting the issue, drawing significant attention.
According to the report, Dr. Yunus, a Nobel Peace Prize laureate, assumed leadership of the interim government following the ouster of Sheikh Hasina’s regime in August 2024. However, he has expressed frustration over the lack of adequate support to conduct elections, stating on Thursday that he would step down if not allowed to work freely.
Citing a senior official from the interim government, The New York Times reported that Dr. Yunus had already drafted a resignation letter. His advisers, however, persuaded him that resigning at this juncture could further destabilize Bangladesh. A recent statement by Army Chief General Waker-Uz-Zaman advocating for elections by December has reportedly added to Dr. Yunus’s discontent, as he believes more time, possibly until June 2026, is needed for a fair electoral process.
Political analyst Mobashar Hasan told The New York Times, “Dr. Yunus may be an excellent banker and institutional leader, but he lacks the strong personality required for political leadership.” Hasan also suggested that Dr. Yunus is heavily influenced by his advisers.
Speculation about Dr. Yunus’s potential resignation has been rife on social media, with many expressing concerns that his departure could exacerbate political instability. However, Foyez Ahmad Taiyeb, Dr. Yunus’s special assistant for ICT, stated on Facebook, “Dr. Yunus does not need power, but his leadership is essential for Bangladesh’s peaceful democratic transition.”
The situation has intensified discussions about Bangladesh’s political future and democratic process. The international community, which has placed confidence in Dr. Yunus’s leadership, is closely monitoring developments.
AI/MR
